No. 23A421

Magellan Technology, Inc. v. Food and Drug Administration

Lower Court: Second Circuit
Docketed: 2023-11-15
Status: Presumed Complete
Type: A
Experienced Counsel
Tags: administrative-law arbitrary-and-capricious circuit-split evidentiary-standards fair-notice fda-regulation
Latest Conference: N/A
Question Presented (AI Summary)

Whether the FDA's marketing denial order for electronic nicotine delivery system (ENDS) products was arbitrary and capricious by changing evidentiary standards without fair notice to regulated parties

Question Presented (OCR Extract)

No question identified. : RULE 29. 6

Docket Entries

2023-11-17
Application (23A421) granted by Justice Sotomayor extending the time to file until January 22, 2024.
2023-11-13
Application (23A421) to extend the time to file a petition for a writ of certiorari from November 23, 2023 to January 22, 2024, submitted to Justice Sotomayor.
Main DocumentLower Court Orders/OpinionsLower Court Orders/OpinionsProof of ServiceMain DocumentLower Court Orders/Opinions

Attorneys

Magellan Technology, Inc.
Eric N. Heyer — Thompson Hine LLP, Petitioner
Eric N. Heyer — Thompson Hine LLP, Petitioner
United States Food and Drug Administration
Elizabeth B. Prelogar — Solicitor General, Respondent
Elizabeth B. Prelogar — Solicitor General, Respondent